FDA Approves Omega 3 Health Claim, Industry Applauds Decision

WASHINGTON; The U.S. Food and Drug Administration (FDA) permits nutrient content claims for foods containing specific omega 3 fatty acids DHA (docosahexaenoic acid), EPA (eicosapentanoic acid) and ALA (alpha-linolenic acid), as 3 omega may help reduce the risk of coronary heart disease. As the FDA declined to respond within the required 120-day time period to a petition submitted on behalf of three Washington-based seafood processors, the approval became retroactive Jan. 16 2004.

FDA's approval was applauded by many in the food and supplement industry, as well as health professionals. "This development is a major milestone in the long road that we have traveled to educate the public and the food and nutritional product industries on the unique nutritional benefits provided by flaxseed," said Glenn Pizzey, co-founder and executive vice president research & operations for Pizzey's Milling. Alaska senator Lisa Murkowski also celebrated the health claim and spoke on behalf of Alaska's fishing industry. "This decision is great news for the Alaska seafood industry and for health-conscious consumers....

Acceptance of these claims by the Food and Drug Administration will allow our seafood processors and sellers, especially our salmon fisheries, to highlight for consumers products that contain high levels of DHA and EPA.

FDA's responsible handling of this notification allows consumers to receive information that promises to improve public health."

Return to your health with Omega 3 hemp oil